Press
Office

Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended, and more. Please note not all of this content is available in certain territories.

Blog Categories

Pre-clinical assessment of tobacco-free nicotine pouches demonstrates reduced in-vitro toxicity compared to combustible cigarette smoke

Reduced levels of toxicants in Imperial Brands nicotine pouches translates directly into substantially reduced in-vitro biological activity in recent study As part of our commitment to making a meaningful contribution to tobacco harm reduction (THR), Imperial Brands continues to assess the THR potential of our Next Generation Product (NGP) portfolio relative to combustible tobacco. In […]

8 Mar 2022

Research shows heated tobacco and vape NGP display reduced cardiotoxicity potential relative to combustible cigarette smoke

Pre-clinical assessment using rapid screening Cardio quickPredict assay further substantiates potentially harm reduced alternatives to combustible cigarettes in recent study The smoking of combustible cigarettes has an established association with cardiovascular disease. As part of our commitment to making a meaningful contribution to tobacco harm reduction, Imperial Brands recently evaluated the cardiotoxicity potential of our […]

18 Feb 2022

We celebrate our women in science   

On this day each year, UNESCO shines a light on the key role females are playing in advancing science and technology.  At Imperial Brands, science and innovation are helping drive our transformation into a consumer-focused organisation, committed to making a meaningful contribution to tobacco harm reduction.  To mark UNESCO’s event, we spoke to two of […]

11 Feb 2022

Recent research shows Next Generation Products induce lower biological activity than combustible cigarettes

Novel human cell-based disease screening model compares heated tobacco and vaping product aerosols to combustible cigarette smoke. Imperial Brands continues to investigate the application of innovative in-vitro methodologies to assess the harm reduction potential of our Next Generation Product (NGP) portfolio, relative to combustible tobacco. In this latest study, published in the journal Current Research […]

17 Dec 2021

Pre-clinical testing further substantiates Pulze’s harm reduction potential

TWO NEW PIECES OF IN-VITRO TESTING CONDUCTED BY IMPERIAL BRANDS SCIENCE PRESENT FURTHER EVIDENCE OF HEATED TOBACCO’S HARM REDUCTION POTENTIAL COMPARED TO COMBUSTIBLE CIGARETTE SMOKING. MATTHEW STEVENSON, INVESTIGATIVE AND MECHANISTIC TOXICOLOGY SENIOR MANAGER, EXPLAINS. Pulze is our innovative heated tobacco (HT) device which heats – but doesn’t burn – a portion of reconstituted tobacco contained […]

28 Oct 2021

Imperial Brands Science at CORESTA 2021

IMPERIAL BRANDS IS PRESENTING A NUMBER OF EXCITING RESEARCH PROJECTS AT THIS YEAR’S CORESTA CONGRESS AS PART OF OUR ONGOING SCIENTIFIC SUBSTANTIATION OF OUR NEXT GENERATION PRODUCT PORTFOLIO… CORESTA (Cooperation Centre for Scientific Research Relative to Tobacco) promotes international cooperation in scientific research relating to tobacco and Next Generation Products (NGPs). As a longstanding member […]

11 Oct 2021

Showing 49 to 54 of 116 posts

Subscribe via Email